NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/05/2025
Back to search
Official data from USPTO
BIOCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
09/06/2025
Trademark type
Word
Nice classes
35, 39
Filing date
09/10/2014
Registration date
02/23/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/05/2025
Last transaction
09/06/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/31/1994
First use in commerce
12/31/1994
Drawing code
4
Owner type
03
Owner location
Tempe, AZ
Examiner
DUBRAY, KATHERINE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BIOCARE, INC.
Blood Systems, Inc.
Representatives
Emily A. Bayton Faegre Drinker Biddle & Reath LLP
Technical classification
Nice Classes
Class 35Class 39
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Consignment inventory servicesinventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitalsclinicshome care companieshemophilia and thrombosis centersphysician offices
Class 39
Distribution servicesdelivery of therapeutic plasma-derivatives and recombinant coagulation products used for hemophilia and thrombophilia treatmentimmunologywound managementcritical care; biopharmaceutical and specialty pharmaceutical distribution servicestransportdeliverypackaging and storage of therapeutic plasma-derivatives and recombinant coagulation products for hospitalsclinicshome care companieshemophilia and thrombosis centersphysician offices
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/05/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/05/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/05/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
05/02/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/23/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/29/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/29/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/28/2022
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
06/23/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/22/2022
E815
TEAS SECTION 8 & 15 RECEIVED
01/19/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/23/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/11/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/17/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
02/23/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/08/2015
PUBO
PUBLISHED FOR OPPOSITION
12/08/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/18/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/02/2015
ALIE
ASSIGNED TO LIE
10/28/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/22/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2015
DOCK
ASSIGNED TO EXAMINER
05/21/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/21/2015
GNFR
FINAL REFUSAL E-MAILED
04/21/2015
CNFR
FINAL REFUSAL WRITTEN
04/21/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/25/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/25/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2014
GNRT
NON-FINAL ACTION E-MAILED
12/21/2014
CNRT
NON-FINAL ACTION WRITTEN
12/21/2014
DOCK
ASSIGNED TO EXAMINER
12/21/2014
MPMK
NOTICE OF PSEUDO MARK E-MAILED
09/19/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/18/2014
NWAP
NEW APPLICATION ENTERED
09/13/2014
Continuous trademark protection
Get notified about every new filing that threatens BIOCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.